ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma.

James Brugarolas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.